Protecting Ocean Regions With Robotics: Unleashing the Potential of Marine Bioprospecting
The Rising Demand for Marine Bioprospecting
The world faces an increasing burden of chronic illnesses and an aging population, pushing the healthcare industry towards innovative solutions. This shift emphasizes the need for marine bioprospecting—exploring marine environments for novel compounds that could revolutionize the biopharmaceutical industry.
Marine bioprospecting involves searching for unique compounds within the ocean that offer potential therapeutic benefits. This field has seen tremendous growth due to technological advancements in ocean exploration and the vast genetic diversity found in marine life. Currently, approximately 18,000 natural products have been identified from around 4,800 marine species, with the number of discoveries increasing annually.
Advances in Drug Discovery
Biopharmaceuticals have marked a revolution in modern medicine, offering treatments with high efficacy and minimal side effects. With over 70% of new chemical entities in antimicrobial and anticancer treatments derived from natural products, marine ecosystems have emerged as a significant source. For instance, the U.S. National Cancer Institute found that 1% of marine samples exhibited anti-tumor potential, a stark contrast to the 0.01% from terrestrial sources.
Technological advancements, such as robotics and automated imaging, have vastly improved our ability to screen and analyze small molecules efficiently. These innovations have broadened the potential for marine bioprospecting in drug discovery.
Marine Bioprospecting in Australia
Australia, one of 17 mega-diverse countries, stands at the forefront of marine bioprospecting due to its unique biodiversity. With a significant proportion of endemic species, Australia’s marine environment hosts the world’s largest variety of tropical and temperate seagrass species, mangroves, and coral reefs. These ecosystems provide a rich source of marine compounds for bioprospecting.
Australia’s strong regulatory framework, economic stability, and advanced scientific capacity make it an attractive hub for research and development in the natural product space. The country’s commitment to biopharmaceutical research is evident in its growing number of biotechnology institutes and government support.
Untapped Potential in Marine Ecosystems
The marine biome remains largely unexplored, offering vast opportunities for groundbreaking discoveries. Biopharmaceuticals, a rapidly growing sector in the pharma market, rely heavily on innovations from marine bioprospecting. The untapped potential within marine ecosystems, especially in extreme environments like hydrothermal vents and deep-sea trenches, presents significant prospects for new discoveries.
Areas such as coral reefs, covering just 0.1% of the ocean surface but hosting 25% of all marine species, are rich in biochemical compounds with potential medicinal applications. Historical use of coral-derived substances in pharmaceuticals indicates the vast possibilities awaiting exploration.
Successful Examples of Marine Bioprospecting
Aplidin
Derived from the tunicate Aplidium albicans, Aplidin is an anti-tumor, anti-viral, and immunosuppressive drug effective in treating various cancers. This compound exemplifies marine bioprospecting’s potential in drug discovery, offering new treatment avenues for multiple myeloma and leukemia.
Yondelis
Developed by PharmaMar, Yondelis, containing Trabectedin extracted from sea squirts, addresses soft-tissue sarcoma and ovarian cancer. This semi-synthetically produced compound highlights the innovation possible through marine bioprospecting with minimal environmental impact.
Pro Osteon
Pro Osteon utilizes coral structures to create bone graft implants that mimic human bone. Its effectiveness lies in coral’s natural porous structure, which is transformed into osteoconductive hydroxyapatite. The sustainability of this approach, relying less on natural coral harvesting, emphasizes the eco-friendly nature of marine bioprospecting.
Overcoming Challenges in Marine Bioprospecting
Despite the promise of marine bioprospecting, challenges persist, such as the need for sustainable practices and understanding ecological impacts. With only a few nations able to conduct bioprospecting independently due to high costs, international cooperation becomes vital. The legal and regulatory frameworks remain complex, requiring careful navigation to ensure fair distribution of benefits and conservation of marine biodiversity.
The Role of Robotics in Marine Exploration
Advancements in robotics, such as remotely operated vehicles (ROVs), have minimized human disruption to marine habitats, allowing for non-invasive research. The use of robotic technologies like Liquid Robotics’ Wave Glider facilitates the collection of crucial marine data, paving the way for sustainable bioprospecting practices.
Encouraging Public-Private Partnerships
Partnerships like the Griffith University and Astra